Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Slovenia Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Our updated forecasts for Slovenia's pharmaceutical and healthcare expenditure indicate a rebound this year from a decline trend that was seen over the past three years. Admittedly, this is true in local currency terms, while th...
Feb 2015 $ 1295
Romania Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: We expect Romania's pharmaceutical market in 2015 to be initially driven by a consumer-led recovery as falling fuel and food prices, rising wages and declining unemployment drive pharmaceutical consumption, but local regulatory ...
Feb 2015 $ 1295
Myanmar Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: New investment reforms lifting restrictions on the foreign funding of medicine production will make Myanmar an attractive market to international generic drugmakers. This is due to the opportunity of securing a first-mover advan...
Feb 2015 $ 1295
Lebanon Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Lebanon's healthcare system is under enormous strain as the number of Syrian refugees seeking treatment in the country has sharply risen. Continued political instability will negatively impact government policy regarding healthc...
Feb 2015 $ 1295
France Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: France will remain among the largest pharmaceutical markets worldwide in the coming years, especially due to a large and aging population, as well as high per capita spending levels on medicines. However, several cost-containmen...
Feb 2015 $ 1295
Canada Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Supported by strong democratic institutions and a long history of stable political Leadership, Canada is home to the second largest pharmaceutical market in the Americas and one of the largest in world. We believe that drugmaker...
Feb 2015 $ 1295
Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada
By Renub Research
The improvement in technology, surgical techniques and immunosuppressive drugs, Kidney transplantation has became the preferred treatment for chronic kidney disease for many people. A transplant may offer the best chance of returning to a more nor...
Feb 2015 $ 900
Tanzania Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Tanzania's pharmaceutical market will continue to see growth with the continuing expansion of the country's National Health Insurance Fund. We highlight opportunities in the Tanzanian healthcare market which have come about than...
Feb 2015 $ 1295
Singapore Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceutical companies due to minimal levels of operational risks and the government's support for the industry. The pharmaceutical industry has be...
Feb 2015 $ 1295
Poland Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; any negative economic developments will have an impact on the market in the short term. Over the past five years, Poland's economic outperforma...
Feb 2015 $ 1295
Peru Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for quality control will continue to make Peru an appealing destination for drugmakers. However, while the pharmaceutical and healthcare markets ...
Feb 2015 $ 1295
New Zealand Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Despite policy initiatives designed to increase the pace of generic penetration, high latent demand for branded pharmaceuticals will continue to be underpinned by New Zealand's ageing and expanding population. However, the conve...
Feb 2015 $ 1295
Mozambique Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Mozambique's agricultural industry and natural resources contribute to its rapidly expanding economy, which will allow the Mozambican government to continue the development of healthcare infrastructure. The country's healthcare ...
Feb 2015 $ 1295
Mauritius Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: With high per-capita pharmaceutical expenditure and a stong governmental interest in pharmaceutical development, combined with a rising demand for non-communicable and chronic disease therapies, Mauritius plays host as an attrac...
Feb 2015 $ 1295
Jordan Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Jordan's government is attempting to achieve universal healthcare coverage, which we believe will become increasingly possible following the decision to no longer provide free medical treatment to Syrian refugees in Jordan. The ...
Feb 2015 $ 1295
Japan Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Japan's healthcare system will come under increasing financial strain due to the ageing population and the high use of patented medicines. This provides an impetus for the government to use cost containment measures including po...
Feb 2015 $ 1295
Hong Kong Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: The Hong Kong government will continue to shift healthcare provision towards the private sector due to the growing financial strain and an overburdened public healthcare system. While this could create cost barriers to medicines...
Feb 2015 $ 1295
Germany Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: One of the largest markets in Europe, Germany will continue to experience rising demand for pharmaceuticals, sustained by an ageing population with a strong bias towards patented medicines. In spite of this, additional restricti...
Feb 2015 $ 1295
Bulgaria Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: In 2015, we expect the fallout from the banking and NHIF funding crises to impact pharmaceutical and healthcare spending, but given the passage of reforms to healthcare financing, we hold a more positive view for the long term d...
Feb 2015 $ 1295
Argentina Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Despite economic activity forecast to continue to decline over the medium-term, Argentina's gradual transition towards more pragmatic and market-friendly economic policies will likely benefit key economic sectors in the long-ter...
Feb 2015 $ 1295
Pakistan Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Pakistan's epidemiological profile will undergo a transition as the burden of non-communicable diseases rises and communicable diseases decline. However, despite the clear need for medical care, poor medical infrastructure, low ...
Feb 2015 $ 1295
Israel Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Israel offers an attractive pharmaceutical market, with the government committed to developing the public healthcare system. An improving intellectual property regime and high penetration of patented medicines will be seen as po...
Feb 2015 $ 1295
Gabon Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Spending on pharmaceuticals in Gabon will be driven by the continued development of the country's National Health Insurance Scheme, and particularly by the expansion of the list of reimbursable drugs this quarter. Commercial opp...
Feb 2015 $ 1295
Czech Republic Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: With recently implemented cost-saving measures, legislative changes, and health insurance reforms, the Czech Republic is set to recover from its recent period of stagnancy and decline. Indeed, these changes will help to provide ...
Feb 2015 $ 1295
Colombia Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: President Juan Manuel Santos continues to push forward healthcare reform for medicine price controls and regulatory reformation. Though, such reforms still leave scepticism as Colombia's struggling economy and expanding counterf...
Feb 2015 $ 1295
Live Chat
Live Chat by Comm100